The iVF Clinic in Rīga offers new diagnosis of male infertility – molecular testing of the AZF region of the Y chromosome.
Microdeletion syndrome of the Y chromosome as a genetically determined factor in male infertility
The Y chromosome as a factor in determining gender
As we all know, a normal set of human chromosomes (also known as the karyotype) consists of 23 pairs of chromosomes (46 in all). 22 of the pairs are the same for women and men, but the remaining pair consists of gender chromosomes that determine the gender of the individual – XX for women and XY for men. The normal karyotype for women, thus, is 46,XX, while the normal one for men is 46,XY. During pregnancy, if the embryo has a masculine set of chromosomes, the Y chromosome determines the masculine development of the embryo. Testes are the first to develop, and the testosterone that they produce stimulates the ongoing global process of masculinisation. Most genes in the Y chromosome ensure the genesis of sperm throughout the man’s life if the health of the individual is normal.
The role of the Y chromosome in male infertility
It is important to note that if the Y chromosome is subject to mutation, one problem can be microdeletion syndrome, also known as the azoospermia factor (AZF). This hinders the genesis of sperm or completely blocks it. This is azoospermia or oligospermia, which can cause male infertility. Klinefelter Syndrome (karyotype 47,XXY) involves AZF microdeletion, and that is the most frequent diagnosis for male infertility. AZF microdeletion is found, on average, in one man per 4,000, though according to various studies the percentage of infertile males in a population can be between 2 and 17%. The AZF region of the Y chromosome consists of three sub-regions (AZFa, AZFb and AZFc), so there can be various types of microdeletion (see table). This determines the manifestations of the syndrome’s phenotype or the extent to which the patient is infertile.
|Type of deletion||Frequency of occurrence||Clinical manifestation|
|AZFa||0.5-4%||Azoospermia (Sertoli Syndrome)|
|AZFc||~80%||Oligospermia or azoospermia|
The molecular diagnosis of the genetic status of the microdeletion of the Y chromosome is of primary importance in determining male infertility factors as part of reproductive medicine. The results of the diagnosis will determine what couples who wish to become parents can do. The genetic laboratory of the iVF Rīga clinic is offering a new diagnostic approach for male infertility. This involves the molecular testing of the AZF region of patients with the following indications:
- Oligospermia <5 x 106/mL
- ICSI manipulation
Molecular testing of the AZF region is not indicated for men with other chromosomal aberrations (apart from 46,XY/45,X), obstructive azoospermia or hypogonadotropic hypogonadism. Clinical findings such as the level of hormones, the size of testes, varicocelles, undeveloped testes, etc., have no predictive value when it comes to the genetic status of the AZF region.